Scientific Sessions 2025  /  Drugs and Hypertension – New Treatments Causing Hypertension and New Mechanisms for Treatment  /  Treatment of hypertension caused by cancer therapeutics targeting VEGF pathways
Logo

American Heart Association

  25
  0

Final ID:

Treatment of hypertension caused by cancer therapeutics targeting VEGF pathways

  • Waliany, Sarah  ( Harvard University , Boston , Massachusetts , United States )
  • Witteles, Ronald  ( STANFORD UNIVERSITY SCHOOL OF MED , Stanford , California , United States )
    • Author Disclosures:
    Sarah Waliany: DO have relevant financial relationships ; Consultant:AstraZeneca:Past (completed) | Ronald Witteles: DO have relevant financial relationships ; Advisor:Pfizer:Active (exists now) ; Advisor:Alexion:Past (completed) ; Advisor:BridgeBio:Active (exists now) ; Advisor:Astra Zeneca:Past (completed) ; Advisor:Alnylam:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Drugs and Hypertension – New Treatments Causing Hypertension and New Mechanisms for Treatment

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
RNA interfering agents

Desai Akshay, Webb David

Endothelin receptor antagonists

Blazek Olivia, Flack John

More abstracts from these authors:
How does the co-occurence of atrial fibrillation and amyloidosis impact management?

Witteles Ronald, Garcia-pavia Pablo

AL Cardiac Amyloidosis: A High Risk, High Reward Condition with Contemporary Treatment

Maurer Mathew, Witteles Ronald

You have to be authorized to contact abstract author. Please, Login
Not Available